SCHEMBL28052817

SCHEMBL28052817

Nc1cccc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 2/20 0.70
PTGS1 P23219 3/20 0.65
MAPT P10636 3/20 0.63
MEN1 O00255 1/20 0.63
HTT P42858 1/20 0.63
RAB9A P51151 1/20 0.63
KMT2A Q03164 1/20 0.63
ALDH1A1 P00352 2/20 0.61
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA2 P00918 2/20 0.57
CA9 Q16790 2/20 0.57
KDR P35968 2/20 0.57
BAZ1A Q9NRL2 1/20 0.55
MTOR P42345 1/20 0.55
P2RX1 P51575 1/20 0.54
TP53 P04637 1/20 0.53
GAA P10253 1/20 0.53
TRPV1 Q8NER1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17122422 0.92 MAPT (0.74) DDX3XPTGS1MAPTMEN1HTT
SCHEMBL30969167 0.88 PTGS1 (0.74) DDX3XPTGS1MAPTMEN1HTT
SCHEMBL17664317 0.84 KMT2A (0.81) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL30314470 0.83 DDX3X (1.00) DDX3XPTGS1MAPTMEN1HTT
SCHEMBL1657499 0.83 DDX3X (1.00) DDX3XPTGS1MAPTMEN1HTT
SCHEMBL671986 0.82 MAPT (0.78) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL30101230 0.82 KMT2A (0.90) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL5597699 0.82 KMT2A (0.90) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL11003476 0.82 MAPT (0.68) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL16246935 0.82 KMT2A (0.77) PTGS1MAPTMEN1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103354809-A Arylurea compound, intermediate and use thereof SHANGHAI INST PHARM INDUSTRY 2013-10-16 CN claimed
CN-103354809-B A kind of aryl urea compounds, its intermediate and application thereof SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2016-01-13 CN disclosed